He plans to build another world-class brain tumor center and our team at ABC2 looks forward to working with him.
ABC2 is funding the whole exome sequencing of NeoVax tumors at the Broad Institute to assist Dana-Farber researchers.
Karin Mallory is taking action after her father's brain cancer diagnosis. She's producing The Steel Wheels Benefit Concert for ABC2. It will be streamed live via “Concert Window” on March 28th.
An interview with Max Wallace, CEO of Accelerate Brain Cancer Cure.
Max Wallace, CEO of ABC², responds to the op-ed piece by Llewellyn Hinkes-Jones published this week in the New York Times.
Concert proceeds benefit Accelerate Brain Cancer Cure.
ABC2-funded research in the news and a blog post by Al Musella, of the Musella Foundation, about Novocure's promising Optune trial results.
Accelerate Brain Cancer Cure funded Duke University's early work on the vaccine.
Proceeds to benefit Accelerate Brain Cancer Cure.
Second Brain Tumor Clinical Trial Endpoints Workshop identified steps needed to include measures of patient signs, symptoms, and function as part of evaluation of therapy benefit.
ABC2 CEO Max Wallace chaired the gathering of NCI experts and cancer advocates.
Principal Investigators, based in the state of Florida, are invited to apply. Proposal deadline: December 15, 2014.
ABC2 funds project between UC San Diego Health System and Regulus Therapeutics Inc.
Dr. Jim Olson and his scientific team will begin injecting brain cancer patients with the cancer detecting Tumor Paint made from the venom of deathstalker scorpions.
ABC2's Fall Associate Sierra Alef-Defoe explores the pediatric brain cancer research landscape in honor of her friend Sydney and in recognition of National Childhood Cancer Awareness Month.
A TV news interview with 5k founder Greg Schnoor about the upcoming event and his support for ABC2.
NCI Director Harold Varmus, ABC2 CEO Max Wallace and prominent cancer researchers exchanged ideas with leading pediatric cancer advocates.
The panel focused on new funding models for disease research foundations, including for-profit direct investment in early stage biotech/medtech companies.
The 17 member advisory panel will help PBTF evaluate research funding priorities and guide investments.
Drs. Linda Liau and Albert Lai discussed the future of brain cancer research with ABC2 CEO Max Wallace and brain tumor community guests.
Our beloved ABC2 teammate Mark Green was recently interviewed by our good friend Alex Case about living with brain cancer.
Drs. Maria Castro and Pedro Lowenstein, both of the U-M Department of Neurosurgery, co-led the research.
Guest blogger Lisa Peabody shares her personal story and her experience as an advocate at the recent Alliance for Childhood Cancer Action Day.
ABC2 helped fund the early-stage research by Dr. Andrew Parsa that is now being developed by Agenus.